Related references
Note: Only part of the references are listed.Human pancreatic cancer progression: an anarchy among CCN-siblings
Sushanta K. Banerjee et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2016)
Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition
Gargi Maity et al.
LABORATORY INVESTIGATION (2015)
Estrogen metabolites and breast cancer
Richard J. Santen et al.
STEROIDS (2015)
Mechanisms of estrogen carcinogenesis: The role of E2/E1-quinone metabolites suggests new approaches to preventive intervention - A review
James D. Yager
STEROIDS (2015)
FOXK2 Transcription Factor Suppresses ERα-positive Breast Cancer Cell Growth Through Down-Regulating the Stability of ERα via mechanism involving BRCA1/BARD1
Ying Liu et al.
SCIENTIFIC REPORTS (2015)
CCN5/WISP-2 promotes growth arrest of triple-negative breast cancer cells through accumulation and trafficking of p27Kip1 via Skp2 and FOXO3a regulation
I. Haque et al.
ONCOGENE (2015)
AICT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2+ breast tumor cells from Balb-neuT mice
Nicole Grabinski et al.
CELLULAR SIGNALLING (2014)
Transcriptional Repression of Estrogen Receptor α Signaling by SENP2 in Breast Cancer Cells
Thiziri Nait Achour et al.
MOLECULAR ENDOCRINOLOGY (2014)
Pin1 modulates ERα levels in breast cancer through inhibition of phosphorylation-dependent ubiquitination and degradation
P. Rajbhandari et al.
ONCOGENE (2014)
The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation
J. Zhu et al.
ONCOGENE (2014)
Loss of WISP2/CCN5 in Estrogen-Dependent MCF7 Human Breast Cancer Cells Promotes a Stem-Like Cell Phenotype
Nathalie Ferrand et al.
PLOS ONE (2014)
Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer
Fahimeh Falahi et al.
BREAST CANCER RESEARCH (2014)
Growth Rate Analysis and Efficient Experimental Design for Tumor Xenograft Studies
Gregory Hather et al.
CANCER INFORMATICS (2014)
Histone acetyltransferase Hbo1 destabilizes estrogen receptor a by ubiquitination and modulates proliferation of breast cancers
Masayoshi Iizuka et al.
CANCER SCIENCE (2013)
Regulation of Estrogen Receptor alpha N-Terminus Conformation and Function by Peptidyl Prolyl Isomerase Pin1
Prashant Rajbhandari et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Twist contributes to hormone resistance in breast cancer by downregulating estrogen receptor-α
F. Vesuna et al.
ONCOGENE (2012)
CCN5/WISP-2: A micromanager of breast cancer progression
Sushanta K. Banerjee et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2012)
Clinical significance of estrogen receptor phosphorylation
Leigh C. Murphy et al.
ENDOCRINE-RELATED CANCER (2011)
Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets
Joon-Il Jun et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
BRCA1 Regulates Acetylation and Ubiquitination of Estrogen Receptor-alpha
Yongxian Ma et al.
MOLECULAR ENDOCRINOLOGY (2010)
Trichostatin A enhances acetylation as well as protein stability of ER alpha through induction of p300 protein
Sung-Hye Kim et al.
BREAST CANCER RESEARCH (2010)
Transcriptional Regulation of Estrogen Receptor-α by p53 in Human Breast Cancer Cells
Stephanie Harkey Shirley et al.
CANCER RESEARCH (2009)
Methylation of the TWIST1 Promoter, TWIST1 mRNA Levels, and Immunohistochemical Expression of TWIST1 in Breast Cancer
Eelke H. Gort et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
CCN5/WISP-2 expression in breast adenocarcinoma is associated with less frequent progression of the disease and suppresses the invasive phenotypes of tumor cells
Snigdha Banerjee et al.
CANCER RESEARCH (2008)
The cancer stem cell hypothesis: in search of definitions, markers, and relevance
Michail Shipitsin et al.
LABORATORY INVESTIGATION (2008)
被撤回的出版物: Sensitizing estrogen receptor-negative breast cancer cells to tamoxifen with OSU-03012, a novel celecoxib-derived phosphoinositide-dependent protein kinase-1/Akt signaling inhibitor (Retracted article. See vol. 18, pg. 869, 2019)
Shu-Chuan Weng et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Role of WISP-2/CCN5 in the maintenance of a differentiated and noninvasive phenotype in human breast cancer cells
Asmaa Fritah et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Breast cancer: origins and evolution
Kornelia Polyak
JOURNAL OF CLINICAL INVESTIGATION (2007)
CCN5 expression in mammals
Jennifer A. Jones et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2007)
Unraveling the mechanisms of endocrine resistance in breast cancer: New therapeutic opportunities
Suleiman Massarweh et al.
CLINICAL CANCER RESEARCH (2007)
Amphiregulin is an essential mediator of estrogen receptor α function in mammary gland development
Laura Ciarloni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Insulin-like growth factor-1 (IGF-1) induces WlSP-2/CCN5 via multiple molecular cross-talks and is essential for mitogenic switch by IGF-1 axis in estrogen receptor-positive breast tumor cells
Kakali Dhar et al.
CANCER RESEARCH (2007)
Limitations of green fluorescent protein as a cell lineage marker
E. Scott Swenson et al.
STEM CELLS (2007)
Estrogen receptor positive breast cancer metastasis: Altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes
Joshua Chuck Harrell et al.
CANCER RESEARCH (2006)
Paracrine signaling through the epithelial estrogen receptor α is required for proliferation and morphogenesis in the mammary gland
S Mallepell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Epigenetic information and estrogen receptor alpha expression in breast cancer
Laura Giacinti et al.
ONCOLOGIST (2006)
Relevance of breast cancer cell lines as models for breast tumours: an update
M Lacroix et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
Forkhead box transcription factor FOXO3a regulates estrogen receptor alpha expression and is repressed by the Her-2/neu/phosphatidylinositol 3-kinase/Akt signaling pathway
SQ Guo et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Conditional overexpression of active transforming growth factor β1 in vivo accelerates metastases of transgenic mammary tumors
RS Muraoka-Cook et al.
CANCER RESEARCH (2004)
The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer
DC Allred et al.
BREAST CANCER RESEARCH (2004)
Update on animal models developed for analyses of estrogen receptor biological activity
KS Korach et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2003)
WISP-2 gene in human breast cancer: Estrogen and progesterone inducible expression and regulation of tumor cell proliferation
S Banerjee et al.
NEOPLASIA (2003)
Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis
SE Moody et al.
CANCER CELL (2002)
Neuropilin-1 is differentially expressed in myoepithelial cells and vascular smooth muscle cells in preneoplastic and neoplastic human breast: A possible marker for the progression of breast cancer
JM Stephenson et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
The multifaceted mechanisms of estradiol and estrogen receptor signaling
JM Hall et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Estrogen receptor interaction with estrogen response elements
CM Klinge
NUCLEIC ACIDS RESEARCH (2001)
Estrogen receptors α and β exhibit different estradiol and estrogen response element binding in the presence of nonspecific DNA
VV Tyulmenkov et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2001)
WISP-2: A serum-inducible gene differentially expressed in human normal breast epithelial cells and in MCF-7 breast tumor cells
MN Zoubine et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
C/EBP beta (CCAAT/enhancer binding protein) controls cell fate determination during mammary gland development
TN Seagroves et al.
MOLECULAR ENDOCRINOLOGY (2000)
Share Paper
